Dr Ing Hc Stock Five Year Return
| DRPRF Stock | USD 61.80 0.28 0.45% |
Dr Ing hc fundamentals help investors to digest information that contributes to Dr Ing's financial success or failures. It also enables traders to predict the movement of DRPRF Pink Sheet. The fundamental analysis module provides a way to measure Dr Ing's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Ing pink sheet.
DRPRF |
Dr Ing hc Company Five Year Return Analysis
Dr Ing's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Dr Ing hc has a Five Year Return of 0.0%. This indicator is about the same for the Consumer Cyclical average (which is currently at 0.0) sector and about the same as Auto Manufacturers (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
DRPRF Fundamentals
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Shares Owned By Insiders | 7.00 % | |||
| Shares Owned By Institutions | 13.52 % | |||
| Revenue | 36.76 B | |||
| Gross Profit | 8.99 B | |||
| EBITDA | 9.38 B | |||
| Net Income | 4.03 B | |||
| Cash And Equivalents | 5.87 B | |||
| Cash Per Share | 64.53 X | |||
| Total Debt | 9.75 B | |||
| Debt To Equity | 0.65 % | |||
| Current Ratio | 1.12 X | |||
| Book Value Per Share | 251.94 X | |||
| Cash Flow From Operations | 6.42 B | |||
| Number Of Employees | 36.52 K |
About Dr Ing Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Ing hc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Ing using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Ing hc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in DRPRF Pink Sheet
Dr Ing financial ratios help investors to determine whether DRPRF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRPRF with respect to the benefits of owning Dr Ing security.